Galera Therapeutics, Inc., a biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer. The company’s lead product is tilarginine that is in Phase 1/2 trial of a pan-inhibitor of nitric oxide synthase to treat pa... Galera Therapeutics, Inc., a biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer. The company’s lead product is tilarginine that is in Phase 1/2 trial of a pan-inhibitor of nitric oxide synthase to treat patients with highly resistant forms of breast cancer, including metaplastic breast cancer (MpBC) and other refractory subsets of triple-negative breast cancer (TNBC). It develops avasopasem manganese, a small molecule dismutase mimetic for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC). The company was incorporated in 2012 and is based in Malvern, Pennsylvania. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0006 | 0.705052878966 | 0.0851 | 0.095 | 0.084 | 122876 | 0.08622405 | CS |
| 4 | -0.0166 | -16.2267839687 | 0.1023 | 0.1074 | 0.0838 | 62231 | 0.09206543 | CS |
| 12 | 0.0417 | 94.7727272727 | 0.044 | 0.15 | 0.041 | 326097 | 0.08448308 | CS |
| 26 | 0.0632 | 280.888888889 | 0.0225 | 0.15 | 0.021 | 189145 | 0.07595515 | CS |
| 52 | 0.0587 | 217.407407407 | 0.027 | 0.15 | 0.0151 | 142267 | 0.05729448 | CS |
| 156 | -0.0451 | -34.4801223242 | 0.1308 | 0.15 | 0.0151 | 194294 | 0.06877946 | CS |
| 260 | -0.0451 | -34.4801223242 | 0.1308 | 0.15 | 0.0151 | 194294 | 0.06877946 | CS |
Stinger2014
2分前
ipiros
2分前
ProfitScout
2分前
boston127
3分前
BIOChecker4
3分前
work-n-hard
4分前
ollik78
5分前
CK-verse
5分前
wronginvestor
5分前
ProfitScout
6分前
chainma1l
7分前
Investor082
7分前
makinezmoney
7分前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。